CoD-Vaccines-Ex4-V9-st

Next

Next

Prev

Prev

01 — 02

02 — 02

With the inclusion of COVID-19 assets, the number of vaccine programs for infectious diseases has accelerated.

With the removal of COVID-19 assets from the picture, the number of vaccine programs for infectious diseases has remained largely flat.

Image description:
A 2-panel animated area graph shows infectious disease vaccines in development between 2010 and 2023, as a number of products. The first panel shows the total vaccines developed, including those for COVID-19. The second panel shows the same assets but excludes the vaccines developed for COVID-19. The panels highlight the stagnation in vaccine development without the COVID-19 surge.
Source: Pharmaprojects, Nov 2023
End of image description.

Image description:
A 2-panel animated area graph shows infectious disease vaccines in development between 2010 and 2023, as a number of products. The first panel shows the total vaccines developed, including those for COVID-19. The second panel shows the same assets but excludes the vaccines developed for COVID-19. The panels highlight the stagnation in vaccine development without the COVID-19 surge.
Source: Pharmaprojects, Nov 2023
End of image description.